abstract |
The present invention relates to the use of selenate or a pharmaceutically acceptable salt thereof in methods and compositions for enhancing the activity of the protein phosphatase PP2A. Methods of reducing phosphorylation of tau protein, inhibiting activity of GSK3β and treating or preventing alpha-synucleopathies and other Parkinson's like disorders are also described. |